N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Traumatic brain injury (TBI) has become a growing epidemic but no approved pharmacological treatment has been identified. Our previous work indicates that mitochondrial oxidative stress/damage and loss of bioenergetics play a pivotal role in neuronal cell death and behavioral outcome following experimental TBI. One tactic that has had some experimental success is to target glutathione using its precursor N-acetylcysteine (NAC). However, this approach has been hindered by the low CNS bioavailability of NAC. The current study evaluated a novel, cell permeant amide form of N-acetylcysteine (NACA), which has high permeability through cellular and mitochondrial membranes resulting in increased CNS bioavailability. Cortical tissue sparing, cognitive function and oxidative stress markers were assessed in rats treated with NACA, NAC, or vehicle following a TBI. At 15 days post-injury, animals treated with NACA demonstrated significant improvements in cognitive function and cortical tissue sparing compared to NAC or vehicle treated animals. NACA treatment also was shown to reduce oxidative damage (HNE levels) at 7 days post-injury. Mechanistically, post-injury NACA administration was demonstrated to maintain levels of mitochondrial glutathione and mitochondrial bioenergetics comparable to sham animals. Collectively these data provide a basic platform to consider NACA as a novel therapeutic agent for treatment of TBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of Excitatory Amino Acids and NMDA Receptors in Traumatic Brain Injury
Faden, A. I., Demediuk, P., Panter, S. S., & Vink, R. (1989) · Science · doi:10.1126/science.2567056 · Cited by 1,508 · cited 2×
“Associated with this secondary injury cascade is glutamate induced excitotoxicity mediated predominantly by increased intracellular Ca2+ levels (Arundine and Tymianski, 2004; Choi et al., 1987; Faden et al., 1989; Zipfel et al., 2000).”
Background(1999) · doi:10.1097/00001199-199912000-00009 · Cited by 1,387 · cited 1×
“Unfortunately, treatment options are limited as no approved pharmacological therapeutic intervention has been identified thus far (Doppenberg and Bullock, 1997; Royo et al., 2003; Thurman et al., 1999).”
BackgroundMolecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury
Arundine, M., & Tymianski, M. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3319-x · Cited by 647
Antioxidant Therapy in Acute Central Nervous System Injury: Current State
Gilgun-Sherki, Y., Rosenbaum, Z., Melamed, E., & Offen, D. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.271 · Cited by 568 · cited 2×
“The failure of NAC to provide significant improvement in behavioral outcome and tissue sparing is presumably due to its low CNS bioavailability (only 6–10%) and hydrophobicity as reviewed previously (Gilgun-Sherki et al., 2002; Sunitha et al., 2013).”
BackgroundSingh, I. N., Sullivan, P. G., Deng, Y., Mbye, L. H., & Hall, E. D. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600297 · Cited by 367
Self-citationOxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury
Ansari, M. A., Roberts, K. N., & Scheff, S. W. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.038 · Cited by 327
Hoffer, M. E., Balaban, C., Slade, M. D., Tsao, J. W., & Hoffer, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054163 · Cited by 207 · cited 4×
“within 24 h or 72 h after experiencing blast compared to the placebo treatment (Hoffer et al., 2013).”
BackgroundInfluentialHaber, M., Abdel Baki, S. G., Grin'kina, N. M., Irizarry, R., Ershova, A., Orsi, S., Grill, R. J., Dash, P., & Bergold, P. J. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.09.002 · Cited by 95 · cited 6×
“, 2006) but are in agreement with other reports (Abdel Baki et al., 2010; Haber et al., 2013; Thomale et al., 2005, 2006) in experimental TBI models.”
BackgroundResultInfluential
Cited by
Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets
Thapa, K., Khan, H., Singh, T. G., & Kaur, A. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01841-7 · Cited by 341
Coles, L. D., Tuite, P. J., Öz, G., Mishra, U. R., Kartha, R. V., Sullivan, K. M., Cloyd, J. C., & Terpstra, M. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1008 · Cited by 170
A Mild Traumatic Brain Injury in Mice Produces Lasting Deficits in Brain Metabolism
Lyons, D. N., Vekaria, H., Macheda, T., Bakshi, V., Powell, D. K., Gold, B. T., Lin, A.-L., Sullivan, P. G., & Bachstetter, A. D. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5663 · Cited by 55
“Total mitochondria were isolated from the cortex and hippocampus as described previously.(15,16) Synaptic and nonsynaptic mitochondria were isolated from the cortex as described previously.”
MethodSelf-citationAge- and brain region-specific differences in mitochondrial bioenergetics in Brown Norway rats
Pandya, J. D., Royland, J. E., MacPhail, R. C., Sullivan, P. G., & Kodavanti, P. R. S. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.027 · Cited by 50
Self-citationCullen, K. R., Schreiner, M. W., Klimes-Dougan, B., Eberly, L. E., LaRiviere, L. L., Lim, K. O., Camchong, J., & Mueller, B. A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109778 · Cited by 34
“, 2014) and following brain injury (Pandya et al., 2014).”
Metadata
- Authors
- Pandya, J. D., Readnower, R. D., Patel, S. P., Yonutas, H. M., Pauly, J. R., Goldstein, G. A., Rabchevsky, A. G., & Sullivan, P. G.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 257
- Pages
- 106-113
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W1974876299
- Cited by
- 118
- References
- 8
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI. https://app.cochat.ai/papers/10.1016/j.expneurol.2014.04.020
- The paper
- Pandya, J. D., Readnower, R. D., Patel, S. P., Yonutas, H. M., Pauly, J. R., Goldstein, G. A., Rabchevsky, A. G., & Sullivan, P. G. (2014). N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI. Experimental Neurology. https://doi.org/10.1016/j.expneurol.2014.04.020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.